Patient Rating:

4.8 out of 5

32 Patient Ratings
21 Patient Comments

Craig H. Selzman, M.D.

Clinical Details

Locations

Schedule An Appointment Clinical Office Address
(801) 587-9348 University Hospital
Cardiovascular Center
50 N Medical Dr
Salt Lake City, UT 84132
Map

Bio

Dr. Craig Selzman is an Associate Professor of Surgery in the Division of Cardiothoracic Surgery at the University of Utah who specializes in the care of patients requiring heart surgery. He earned his undergraduate degree at Amherst College and medical degree at Baylor College of Medicine. He received his General and Cardiothoracic Surgery training at the University of Colorado and is Board-Certified in both fields. Dr. Selzman was on faculty at the University of North Carolna before joining the faculty at University of Utah in 2008.

Dr. Selzman is the Surgical Director of the Cardiac Mechanical Support and Heart Transplant program as well as Surgical Director of the Lung and Heart/Lung Transplant program. In addition to his role in the advanced Heart Failure and Artifiical Heart program, he specializes in complex valvular heart disease including reoperative heart surgery, adult congenital heart disease, and aortic root reconstruction. He is one of a few surgeons in the Intermountain West with significant experience with minimally invasive heart surgery for a wide variety of disease, and, in particular, mitral valve repair.

Dr. Selzman is heavily involved with clinical research related to advanced heart failure, transplantation, and ventricular assist devices. He also has an active basic science collaboration with many of our researchers here at the University of Utah. Dr. Selzman is one of a handful of cardiothoracic surgeons that runs a laboratory funded by the National Institute of Health. His research focus is related to examining mechanisms of heart recovery.

Board Certification and Academic Information

Academic Departments Surgery - Associate Professor
Academic Divisions Cardiothoracic Surgery
Board Certification American Board of Surgery (General Surgery)
American Board of Thoracic Surgery (Thoracic Surg)

Patient Ratings

The Patient Rating score is an average of all responses to physician related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

Likelihood of recommending doctor
4.8
My confidence in doctor
4.9
Time doctor spent with me
4.8
Doctor spoke using clear language
4.9
Doctor's effort to include me in decisions
4.8
Doctor's concern for questions & worries
4.8
Doctor's explanation of condition/problem
4.8
Wait time at clinic
4.5
Doctor's friendliness and courtesy
4.8

Patient Comments

Patient comments are gathered from our Press Ganey Patient Satisfaction Survey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

February 09, 2014

Dr. Selzman understood the 29 days of hospitalization I had experienced and showed concern for how I was dealing with that. He also quickly assured me that I was now doing fine.

January 17, 2014

Perhaps the best experience I've had with any physician and other care providers in my 66 years.

January 15, 2014

The team was terrific.

January 10, 2014

The care we received here is better than any care we've received elsewhere!

January 10, 2014

my physical response to this corrective surgery has been difficult. Having Dr Selzman and his team provide excellence with attentive and compassionate care made all the difference. Thank you!

December 06, 2013

great

November 21, 2013

Dr.Salizman is wonderful

September 23, 2013

the doctor felt my medical wasn't severe enough to operate. I'm just scared that something more is going to happen with my luck to. I want to know I haven't been forgotten about.

July 15, 2013

We are totally impressed with everyone involved in my surgery, recovery and follow up. Everyone were exceptional professionals.

May 28, 2013

all good

May 13, 2013

Left with no questions. When they did arrise it was convenient to get answers

May 09, 2013

Good experience Staff were very helpful.

April 29, 2013

I was treated like. person. with concern and care. I am asked if I understand my condition and explained what I don't. I am explained what is happening to me. I am reassured that I am in good hands. and I feel at ease because I am being talked to and looked at.

February 18, 2013

Very pleased with the degree of knowledge and concern

January 07, 2013

Terri was very informative during my pre-op visit, great personality and concern. I would highly recommend anyone visiting your practice for sugical intervention to be followed by Dr. Allen. In my opinion, he is the best rounded professional on staff in his position. My family concurs that he was very informative, caring, and aware of my situation whenever he rounded on me. He has a great demeanor and followed through efficiently. I felt that any/all of my concerns were addressed and confident that he would relay them to Dr. Selzman. I didn't get the same quality of care with Dr. Kim.

August 07, 2012

Dr. Salzman is the best

June 25, 2012

The UUH LVAD team is tops in my book!!!

June 24, 2012

Outstanding care and concerns

June 11, 2012

This was a very positive and comforting visit.

April 25, 2012

very good.

February 22, 2012

Good experience as bad health situations go!

Academic Profile

Board Certification and Academic Information

Academic Departments Surgery - Associate Professor
Academic Divisions Cardiothoracic Surgery
Board Certification American Board of Surgery (General Surgery)
American Board of Thoracic Surgery (Thoracic Surg)

Academic Office Locations

Academic Office Phone Number Academic Office Address
(801) 587-9348 School of Medicine
Division of Cardiothoracic Surgery
30 N Medical Dr
Salt Lake City, UT 84132

Academic Bio

As an Associate Professor of Cardiothoracic Surgery in the School of Medicine at the University of Utah, Dr. Selzman is heavily invested in the future of our next generation of physicians and surgeons. He is actively involved with medical student teaching, general surgical education, and training of young cardiac surgeons. He has been involved with educational strategies at the national level through his professional societies. Dr. Selzman has mentored dozens of trainees- both in the clinical and basic sciences - over the last 15 years, many which currently hold faculty positions in academic medical centers.

In addition to his involvement with clinical research (see Clinical Trials), Dr. Selzman has an active, NIH-funded basic science laboratory. He collaborates with many of the investigators within the Molecular Medicine Program and with the Integrated Advanced Heart Failure Program. He has published over 100 manuscripts in peer-reviewed journals as well as authored several textbook chapters. His laboratory is focused on transcriptional regulation and mechanisms of myocardial recovery. His team uses several models for investigation ranging from individual cardiomyocytes to transgenic mice as well as larger translational studies in sheep, goats, and humans.

In addition to his clinical and research responsibilites here at the University of Utah, Dr. Selzman carries many national and international positions including NIH study sections, Thoracic Transplantation committees, and professional organizational responsibilites.

Education

Education History

Type School Degree
Residency University of Colorado at Denver and Health Sciences Center
Cardiothoracic Surgery
Resident
Residency University of Colorado at Denver and Health Sciences Center
Surgery
Resident
Internship University of Colorado at Denver and Health Sciences Center
Surgery
Intern
Professional Medical Baylor College of Medicine
Medicine
M.D.
Undergraduate Amherst College
Political Science
B.A.

Publications

Selected Provider Publications

Journal Article

  1. Wever-Pinzon O, Drakos SG, Kfoury AG, Nativi JN, Gilbert EM, Everitt M, Alharethi R, Brunisholz K, Bader FM, Li DY, Selzman CH, Stehlik (2013)Morbidity and mortality in heart transplant candidates supported with mechanical circulatory support: is reappraisal of the current United network for organ sharing thoracic organ allocation policy justified?  Circulation, 127(4),452-62
  2. Stanfield JR, Selzman C(2013)In vitro pulsatility analysis of axial-flow and centrifugal-flow left ventricular assist devices.  Journal of Biomechanical Engineering, 135(3),34505
  3. Carson P, Wertheimer J, Miller A, O'Connor CM, Pina IL, Selzman C, Sueta C, She L, Greene D, Lee KL, Jones RH, Velazquez E(2013)Surgical Treatment for Ischemic Heart Failure (STICH) Trial: Mode of Death Results.LID - 10.1016/j.jchf.2013.04.012 [doi]  JACC: Heart Failure, 1(5),
  4. Kfoury AG, Snow GL, Budge D, Alharethi RA, Stehlik J, Everitt MD, Miller DV, Drakos SG, Reid BB, Revelo MP, Gilbert EM, Selzman CH, Bader FM, Connelly JJ, Hammond M(2012)A longitudinal study of the course of asymptomatic antibody-mediated rejection in heart transplantation.  The Journal of Heart and Lung Transplantation, 31(1),46-51
  5. Wozniak CJ, Baird BC, Stehlik J, Drakos SG, Bull DA, Patel AN, Selzman C(2012)Improved survival in heart transplant patients living at high altitude.  Journal of Thoracic and Cardiovascular Surgery, 143(3),735-741.e1
  6. Andersen NM, Tang R, Li L, Javan H, Zhang XQ, Selzman C(2012)Inhibitory kappa-B kinase-beta inhibition prevents adaptive left ventricular hypertrophy.  Journal of Surgical Research, 178(1),105-9
  7. Andersen NM, Stansfield WE, Tang RH, Rojas M, Patterson C, Selzman C(2012)Recovery from decompensated heart failure is associated with a distinct, phase-dependent gene expression profile.  Journal of Surgical Research, 178(1),72-80
  8. Drakos SG, Kfoury AG, Stehlik J, Selzman CH, Reid BB, Terrovitis JV, Nanas JN, Li D(2012)Bridge to recovery: understanding the disconnect between clinical and biological outcomes.  Circulation, 126(2),230-41
  9. Stanfield JR, Selzman CH, Pardyjak ER, Bamberg (2012)Flow characteristics of continuous-flow left ventricular assist devices in a novel open-loop system.  ASAIO Journal, 58(6),590-6
  10. Healy AH, Baird BC, Drakos SG, Stehlik J, Selzman C(2012)Impact of Ventricular Assist Device Complications on Posttransplant Survival: An Analysis of the United Network of Organ Sharing Database.LID - S0003-4975(12)02482-4 [pii]LID - 10.1016/j.athoracsur.2012.10.080 [doi]  The Annals of Thoracic Surgery,
  11. Selzman CH, Desjardins G, Patel AN, Davis E, Dick S, Stehlik (2012)Complications associated with the use of left ventricular assist device therapy in an adult patient with Ebstein's anomaly  The Annals of Thoracic Surgery, 93(1),297-9
  12. Revelo MP, Stehlik J, Miller D, Snow GL, Everitt MD, Budge D, Bader FM, Alharethi RA, Gilbert EM, Reid BB, Selzman CH, Hammond ME, Kfoury A(2011)Antibody testing for cardiac antibody-mediated rejection: which panel correlates best with cardiovascular death?  The Journal of Heart and Lung Transplantation, 30(2),144-50
  13. Drakos SG, Kfoury AG, Selzman CH, Verma DR, Nanas JN, Li DY, Stehlik (2011)Left ventricular assist device unloading effects on myocardial structure and function: current status of the field and call for action.  Current Opinion in Cardiology, 26(3),245-55
  14. Nativi JN, Drakos SG, Kucheryavaya AY, Edwards LB, Selzman CH, Taylor DO, Hertz MI, Kfoury AG, Stehlik (2011)Changing outcomes in patients bridged to heart transplantation with continuous- versus pulsatile-flow ventricular assist devices: an analysis of the registry of the International Society for Heart and Lung Transplantation.  The Journal of Heart and Lung Transplantation, 30(8),854-61
  15. Wever Pinzon O, Stoddard G, Drakos SG, Gilbert EM, Nativi JN, Budge D, Bader F, Alharethi R, Reid B, Selzman CH, Everitt MD, Kfoury AG, Stehlik (2011)Impact of donor left ventricular hypertrophy on survival after heart transplant.  American Journal of Transplantation, 11(12),2755-61
  16. Healy AH, Mason NO, Hammond ME, Reid BB, Clayson SE, Drakos SG, Kfoury AG, Patel AN, Bull DA, Budge D, Alharethi RA, Bader FM, Gilbert EM, Stehlik J, Selzman C(2011)Allograft rejection in patients supported with continuous-flow left ventricular assist devices.  The Annals of Thoracic Surgery, 92(5),1601-7; discussion 1607
  17. Nativi JN, Kfoury AG, Myrick C, Peters M, Renlund D, Gilbert EM, Bader F, Singhal AK, Everitt M, Fisher P, Bull DA, Selzman C, Stehlik (2010)Effects of the 2006 U.S. thoracic organ allocation change: analysis of local impact on organ procurement and heart transplantation.  The Journal of Heart and Lung Transplantation, 29(3),235-9
  18. Raymond AL, Kfoury AG, Bishop CJ, Davis ES, Goebel KM, Stoker S, Selzman CH, Clayson SE, Smith H, Cowley CG, Alharethi R, Budge D, Reid B(2010)Obesity and left ventricular assist device driveline exit site infection.  ASAIO Journal, 56(1),57-60
  19. Bull DA, Reid BB, Selzman CH, Mesley R, Drakos S, Clayson S, Stoddard G, Gilbert E, Stehlik J, Bader F, Kfoury A, Budge D, Eckels DD, Fuller A, Renlund D, Patel A(2010)The impact of bridge-to-transplant ventricular assist device support on survival after cardiac transplantation.  Journal of Thoracic and Cardiovascular Surgery, 140(1),169-73
  20. Selzman (2010)Invited commentary.  The Annals of Thoracic Surgery, 90(1),123
  21. Drakos SG, Kfoury AG, Hammond EH, Reid BB, Revelo MP, Rasmusson BY, Whitehead KJ, Salama ME, Selzman CH, Stehlik J, Clayson SE, Bristow MR, Renlund DG, Li D(2010)Impact of mechanical unloading on microvasculature and associated central remodeling features of the failing human heart.  Journal of the American College of Cardiology, 56(5),382-91
  22. Stansfield WE, Charles PC, Tang RH, Rojas M, Bhati R, Moss NC, Patterson C, Selzman C(2009)Regression of pressure-induced left ventricular hypertrophy is characterized by a distinct gene expression profile.  Journal of Thoracic and Cardiovascular Surgery, 137(1),232-8, 238e1-8
  23. Willis MS, Rojas M, Li L, Selzman CH, Tang RH, Stansfield WE, Rodriguez JE, Glass DJ, Patterson (2009)Muscle ring finger 1 mediates cardiac atrophy in vivo.  American Journal of Physiology: Heart and Circulatory Physiology, 296(4),H997-H1006
  24. Drakos SG, Kfoury AG, Kotter JR, Reid BB, Clayson SE, Selzman CH, Stehlik J, Fisher PW, Merida M 3rd, Eckels DD, Brunisholz K, Horne BD, Stoker S, Li DY, Renlund D(2009)Prior human leukocyte antigen-allosensitization and left ventricular assist device type affect degree of post-implantation human leukocyte antigen-allosensitization.  The Journal of Heart and Lung Transplantation, 28(8),838-42
  25. Callis TE, Pandya K, Seok HY, Tang RH, Tatsuguchi M, Huang ZP, Chen JF, Deng Z, Gunn B, Shumate J, Willis MS, Selzman CH, Wang D(2009)MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice.  Journal of Clinical Investigation, 119(9),2772-86
  26. Campbell RA, Overmyer KA, Selzman CH, Sheridan BC, Wolberg A(2009)Contributions of extravascular and intravascular cells to fibrin network formation, structure, and stability.  Blood, 114(23),4886-96
  27. Stansfield WE, Andersen NM, Tang RH, Selzman C(2009)Periostin is a novel factor in cardiac remodeling after experimental and clinical unloading of the failing heart.  The Annals of Thoracic Surgery, 88(6),1916-21
  28. Jones RH, Velazquez EJ, Michler RE, Sopko G, Oh JK, O'Connor CM, Hill JA, Menicanti L, Sadowski Z, Desvigne-Nickens P, Rouleau JL, Lee KL, STICH Hypothesis 2 Investigator(2009)Coronary bypass surgery with or without surgical ventricular reconstruction  New England Journal of Medicine, 360(17),1705-17
  29. Kouretas PC, Kaza AK, Burch PT, Witte MK, Clayson SE, Everitt MD, Selzman C(2009)Experience with the Levitronix CentriMag in the pediatric population as a bridge to decision and recovery  Artificial Organs, 33(11),1002-4
  30. Stansfield WE, Tang RH, Moss NC, Baldwin AS, Willis MS, Selzman C(2008)Proteasome inhibition promotes regression of left ventricular hypertrophy.  American Journal of Physiology: Heart and Circulatory Physiology, 294(2),H645-50
  31. Selzman C(2008)Invited commentary on: Gene Transfer of Endothelial Nitric Oxide Synthase Attenuates Flow-induced Pulmonary Hypertension in Rabbits  The Annals of Thoracic Surgery, 85(2),585-6
  32. Chen JF, Murchison EP, Tang R, Callis TE, Tatsuguchi M, Deng Z, Rojas M, Hammond SM, Schneider MD, Selzman CH, Meissner G, Patterson C, Hannon GJ, Wang D(2008)Targeted deletion of Dicer in the heart leads to dilated cardiomyopathy and heart failure.  Proceedings of the National Academy of Sciences of the United States of America, 105(6),2111-6
  33. Tang RH, Zheng XL, Callis TE, Stansfield WE, He J, Baldwin AS, Wang DZ, Selzman C(2008)Myocardin inhibits cellular proliferation by inhibiting NF-kappaB(p65)-dependent cell cycle progression.  Proceedings of the National Academy of Sciences of the United States of America, 105(9),3362-7
  34. Moss NC, Tang RH, Willis M, Stansfield WE, Baldwin AS, Selzman C(2008)Inhibitory kappa B kinase-beta is a target for specific nuclear factor kappa B-mediated delayed cardioprotection.  Journal of Thoracic and Cardiovascular Surgery, 136(5),1274-9
  35. Stansfield WE, Rojas M, Corn D, Willis M, Patterson C, Smyth SS, Selzman C(2007)Characterization of a model to independently study regression of ventricular hypertrophy.  Journal of Surgical Research, 142(2),387-93
  36. Stansfield WE, Moss NC, Willis MS, Tang R, Selzman C(2007)Proteasome inhibition attenuates infarct size and preserves cardiac function in a murine model of myocardial ischemia-reperfusion injury.  The Annals of Thoracic Surgery, 84(1),120-5
  37. Selzman CH, Sheridan B(2007)Off-pump insertion of continuous flow left ventricular assist devices.  Journal of Cardiac Surgery, 22(4),320-2
  38. Moss NC, Stansfield WE, Willis MS, Tang RH, Selzman C(2007)IKKbeta inhibition attenuates myocardial injury and dysfunction following acute ischemia-reperfusion injury.  American Journal of Physiology: Heart and Circulatory Physiology, 293(4),H2248-53
  39. Warshauer DM, Archer RK, Selzman CH, Tmaddon HS, Mauro M(2007)Aortic pseudoaneurysm from penetrating superior vena cava stent  Radiology, 234(3),901-4
  40. Selzman CH, Chang PP, Vernon-Platt T, Bowen A, Kowalczyk S, Sherican B(2007)Use of the Jarvik 2000 continous flow left ventricular assist device for acute myocardial infarction and cardiogenic shock  Journal of Heart and Lung Transplantation, The, 26(7),756-8
  41. Pathak A, Zhao R, Monroe DM, Roberts HR, Sheridan BC, Selzman CH, Stouffer G(2006)Thrombin generation in vascular tissue.  Journal of Thrombosis and Haemostasis, 4(1),60-7
  42. Gray NA Jr, Selzman C(2006)Current status of the total artificial heart  American Heart Journal, 152(1),4-10
  43. Bhati RS, Sheridan BC, Mill MR, Selzman C(2005)Heart transplantation for progressive cardiomyopathy as a manifestation of MELAS syndrome.  The Journal of Heart and Lung Transplantation, 24(12),2286-9
  44. Zimmerman MA, Reznikov LL, Raeburn CD, Selzman C(2004)Interleukin-10 attenuates the response to vascular injury.  Journal of Surgical Research, 121(2),206-13
  45. Zimmerman MA, Reznikov LL, Sorensen AC, Selzman C(2003)Relative contribution of the TNF-alpha receptors to murine intimal hyperplasia.  American Journal of Physiology: Regulatory, Integrative and Comparative Physiology, 284(5),R1213-8
  46. Selzman CH, Netea MG, Zimmerman MA, Weinberg A, Reznikov LL, Grover FL, Dinarello C(2003)Atherogenic effects of Chlamydia pneumoniae: refuting the innocent bystander hypothesis.  Journal of Thoracic and Cardiovascular Surgery, 126(3),688-93
  47. Selzman CH, Turner AS, Gaynor JS, Miller SA, Monnet E, Harken A(2002)Inhibition of intimal hyperplasia using the selective estrogen receptor modulator raloxifene.  Archives of Surgery, 137(3),333-6
  48. Zimmerman MA, Selzman CH, Reznikov LL, Raeburn CD, Barsness K, McIntyre RC Jr, Hamiel CR, Harken A(2002)Interleukin-11 attenuates human vascular smooth muscle cell proliferation.  American Journal of Physiology: Heart and Circulatory Physiology, 283(1),H175-80
  49. Zimmerman MA, Selzman CH, Reznikov LL, Miller SA, Raeburn CD, Emmick J, Meng X, Harken A(2002)Lack of TNF-alpha attenuates intimal hyperplasia after mouse carotid artery injury.  American Journal of Physiology: Regulatory, Integrative and Comparative Physiology, 283(2),R505-12
  50. Selzman CH, Miller SA, Zimmerman MA, Gamboni-Robertson F, Harken AH, Banerjee (2002)Monocyte chemotactic protein-1 directly induces human vascular smooth muscle proliferation.  American Journal of Physiology: Heart and Circulatory Physiology, 283(4),H1455-61
  51. Kim SH, Reznikov LL, Stuyt RJ, Selzman CH, Fantuzzi G, Hoshino T, Young HA, Dinarello C(2001)Functional reconstitution and regulation of IL-18 activity by the IL-18R beta chain.  Journal of Immunology, 166(1),148-54
  52. Shames BD, McIntyre RC Jr, Bensard DD, Pulido EJ, Selzman CH, Reznikov LL, Harken AH, Meng (2001)Suppression of tumor necrosis factor alpha production by cAMP in human monocytes: dissociation with mRNA level and independent of interleukin-10.  Journal of Surgical Research, 99(2),187-93
  53. Reznikov LL, Shames BD, Barton HA, Selzman CH, Fantuzzi G, Kim SH, Johnson SM, Dinarello C(2000)Interleukin-1beta deficiency results in reduced NF-kappaB levels in pregnant mice.  American Journal of Physiology: Regulatory, Integrative and Comparative Physiology, 278(1),R263-70
  54. Netea MG, Selzman CH, Kullberg BJ, Galama JM, Weinberg A, Stalenhoef AF, Van der Meer JW, Dinarello C(2000)Acellular components of Chlamydia pneumoniae stimulate cytokine production in human blood mononuclear cells.  European Journal of Immunology, 30(2),541-9
  55. Miller SA, Selzman CH, Shames BD, Barton HA, Johnson SM, Harken A(2000)Chlamydia pneumoniae activates nuclear factor kappaB and activator protein 1 in human vascular smooth muscle and induces cellular proliferation.  Journal of Surgical Research, 90(1),76-81
  56. Gaynor JS, Monnet E, Selzman C, Parker D, Kaufman L, Bryant HU, Mallinckrodt C, Wrigley R, Whitehill T, Turner A(2000)The effect of raloxifene on coronary arteries in aged ovariectomized ewes.  Journal of Veterinary Pharmacology and Therapeutics, 23(3),175-9
  57. Shames BD, Zallen GS, McIntryre RC Jr, Bensard DD, Pulido EJ, Miller SA, Pomerantz BJ, Selzman CH, Meng X, Harken A(2000)Chemokines as mediators of diseases related to surgical conditions  Shock, 14(1),1-7
  58. Raeburn CD, Cleveland JC, Selzman CH, Harken A(2000)Ischemic preconditioning in myocardial revascularization with intermittent aortic cross-clamping  Journal of Cardiac Surgery, 15339-340
  59. Gaynor JS, Monnet E, Selzman C, Parker D, Kaufman L, Bryant HU, Mallinckrodt C, Wrigley R, Whitehill T, Turner A(2000)The effect of raloxifene on coronary arteries in aged ovariectomized ewes  Journal of Veterinary Pharmacology and Therapeutics, 23175-179
  60. Reznikov LL, Fantuzzi G, Selzman CH, Shames BD, Barton HA, Bell H, McGregor JA, Dinarello C(1999)Utilization of endoscopic inoculation in a mouse model of intrauterine infection-induced preterm birth: role of interleukin 1beta.  Biology of Reproduction, 60(5),1231-8
  61. Shames BD, Selzman CH, Pulido EJ, Meng X, Meldrum DR, McIntyre RC Jr, Harken AH, Banerjee (1999)LPS-Induced NF-kappaB activation and TNF-alpha release in human monocytes are protein tyrosine kinase dependent and protein kinase C independent.  Journal of Surgical Research, 83(1),69-74
  62. Selzman CH, Shames BD, Reznikov LL, Miller SA, Meng X, Barton HA, Werman A, Harken AH, Dinarello CA, Banerjee (1999)Liposomal delivery of purified inhibitory-kappaBalpha inhibits tumor necrosis factor-alpha-induced human vascular smooth muscle proliferation.  Circulation Research, 84(8),867-75
  63. Selzman CH, Shames BD, McIntyre RC Jr, Banerjee A, Harken A(1999)The NFkappaB inhibitory peptide, IkappaBalpha, prevents human vascular smooth muscle proliferation.  The Annals of Thoracic Surgery, 67(5),1227-31; discussion 1231-2
  64. Pulido EJ, Shames BD, Selzman CH, Barton HA, Banerjee A, Bensard DD, McIntyre RC J(1999)Inhibition of PARS attenuates endotoxin-induced dysfunction of pulmonary vasorelaxation.  The American Journal of Physiology, 277(4 Pt 1),L769-76
  65. Cain BS, Meldrum DR, Meng X, Pulido EJ, Shames BD, Selzman CH, Banerjee A, Harken A(1999)Exogenous calcium preconditions myocardium from patients taking oral sulfonylurea agents.  Journal of Surgical Research, 86(2),171-6
  66. Sheridan BC, Dinarello CA, Meldrum DR, Fullerton DA, Selzman CH, McIntyre RC J(1999)Interleukin-11 attenuates pulmonary inflammation and vasomotor dysfunction in endotoxin-induced lung injury.  The American Journal of Physiology, 277(5 Pt 1),L861-7
  67. Zimmerman MA, Selzman CH, Harken A(1999)Surgical implications of therapeutic angiogenesis  Surgery, 125(3),243-9
  68. Selzman CH, McIntyre RC Jr, Shames BD, Whitehill TA, Banerjee A, Harken A(1998)Interleukin-10 inhibits human vascular smooth muscle proliferation.  Journal of Molecular and Cellular Cardiology, 30(4),889-96
  69. Krupski WC, Selzman CH, Floridia R, Strecker PK, Nehler MR, Whitehill T(1998)Contemporary management of isolated iliac aneurysms.  Journal of Vascular Surgery, 28(1),1-11; discussion 11-3
  70. Meng X, Ao L, Meldrum DR, Cain BS, Shames BD, Selzman CH, Banerjee A, Harken A(1998)TNF-alpha and myocardial depression in endotoxemic rats: temporal discordance of an obligatory relationship.  The American Journal of Physiology, 275(2 Pt 2),R502-8
  71. Selzman CH, Shames BD, Whitehill TA, Harken AH, McIntyre RC J(1998)Class II cytokine receptor ligands inhibit human vascular smooth muscle proliferation.  Surgery, 124(2),318-26; discussion 326-7
  72. Shames BD, Meldrum DR, Selzman CH, Pulido EJ, Cain BS, Banerjee A, Harken AH, Meng (1998)Increased levels of myocardial IkappaB-alpha protein promote tolerance to endotoxin.  The American Journal of Physiology, 275(3 Pt 2),H1084-91
  73. Selzman CH, Gaynor JS, Turner AS, Johnson SM, Horwitz LD, Whitehill TA, Harken A(1998)Ovarian ablation alone promotes aortic intimal hyperplasia and accumulation of fibroblast growth factor.  Circulation, 98(19),2049-54
  74. Shames BD, Selzman CH, Meldrum DR, Pulido EJ, Barton HA, Meng X, Harken AH, McIntyre RC J(1998)Interleukin-10 stabilizes inhibitory kappaB-alpha in human monocytes.  Shock, 10(6),389-94
  75. Selzman CH, Meldrum DR, Cain BS, Meng X, Shames BD, Ao L, Harken A(1998)Interleukin-10 inhibits postinjury tumor necrosis factor-mediated human vascular smooth muscle proliferation.  Journal of Surgical Research, 80(2),352-6
  76. Selzman CH, Gaynor JS, Turner AS, Whitehill TA, Horwitz LD, Harken A(1998)Estrogen replacement inhibits intimal hyperplasia and the accumulation and effects of transforming growth factor beta1.  Journal of Surgical Research, 80(2),380-5
  77. Shames BD, Selzman CH, Meng X, Meldrum DR, Cain BS, Harken A(1998)Genes don't count  Archives of Surgery, 133(6),667-9
  78. Selzman CH, Shames BD, Miller SA, Pulido EJ, Meng X, McIntyre RC Jr, Harken A(1998)Therapeutic implications of interleukin-10 in surgical disease  Shock, 10(5),309-18
  79. Meldrum DR, Cleveland JC Jr, Sheridan BC, Rowland RT, Selzman CH, Banerjee A, Harken A(1997)Alpha-adrenergic activation of myocardial NF kappa B during hemorrhage.  Journal of Surgical Research, 69(2),268-76
  80. Selzman CH, Turner AS, Johnson SM, Cain BS, Harken AH, Whitehill T(1997)Chronic estrogen replacement inhibits aortic intimal hyperplasia independent of serum lipids.  Journal of Cardiac Surgery, 12(4),228-34

Book Chapter

  1. Stansfield WE, Selzman C(In Press, 2013)Mechanical Circulatory Support  ,

Editorial

  1. Selzman C(2012)Invited commentary on "Should patients age 60 and older be bridged to transplant using a contiuous flow left ventricular assist device"  , 94(6),2024
  2. Selzman C(2011)Invited commentary on "Aortic valve cyclic stretch causes increased remodeling activitiy and enhanced serotonin receptor responsiveness"  , 92153-54
  3. Selzman C(2009)Invited commentary on "In-hospital outcomes of off-pump multi-vessel total arterial and conventional artery bypass grafting: single surgeon, single center experience"  , 8853
  4. Selzman C(2009)Invited commentary on "Role of tumor necrosis factor receptor 1 in sex differences of stem cell mediated cardioprotection"  , 87819
  5. Selzman C(2008)Invited commentary on "Gene Transfer of endothelial nitric oxide synthase attenuates flow-induced pulmonary hypertension in rabbits  , 85585-6
  6. Selzman C(2006)NFkappaB decoys to prevent vein graft stenosis Invited Editorial on "inhibitory effects of NFkappaB decoy oligodeoxynucleotides on neointimal hyperplasia in a rabbit vein graft model"  Journal of Molecular and Cellular Cardiology, 41(3),410-2
  7. Selzman C(2006)Invited commentary on "Improved mechanical reliability of the Heartmate XVE left ventricular assist device  , 82(4),1418-1419

Clinical Trials

Clinical Trials

Video & News

News

The Scope Health Sciences Radio

Video